Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

Late complications of radiotherapy for nasopharyngeal carcinoma.

Sumitsawan Y, Chaiyasate S, Chitapanarux I, Anansuthiwara M, Roongrotwattanasiri K, Vaseenon V, Tooncam H.

Auris Nasus Larynx. 2009 Apr;36(2):205-9. doi: 10.1016/j.anl.2008.04.006. Epub 2008 Jul 16.

PMID:
18635325
2.

Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules.

Cengiz M, Ozyar E, Esassolak M, Altun M, Akmansu M, Sen M, Uzel O, Yavuz A, Dalmaz G, Uzal C, Hiçsönmez A, Sarihan S, Kaplan B, Atasoy BM, Ulutin C, Abacioğlu U, Demiral AN, Hayran M.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1347-53. Epub 2005 Sep 19.

PMID:
16169671
3.

High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.

Nakamura RA, Novaes PE, Antoneli CB, Fogaroli RC, Pellizzon AC, Ferrigno R, Maia MA, Salvajoli JV, Pereira AJ, Nishimoto IN.

Cancer. 2005 Aug 1;104(3):525-31.

4.

[Prognostic factors in nasopharyngeal carcinoma in childhood and adolescence].

Cao KJ, Li Y, Xie GF, Hong MH.

Zhonghua Zhong Liu Za Zhi. 2006 Feb;28(2):134-7. Chinese.

PMID:
16750020
5.

[Long-term efficacy of external radiotherapy plus intracavitary hyperfractionated brachytherapy on nasopharyngeal carcinoma].

Lin SJ, Pan JJ, Wu JX, Han L, Pan CZ.

Ai Zheng. 2007 Feb;26(2):208-11. Chinese.

PMID:
17298755
6.

[T.i.d. accelerated radiotherapy alone or alternating with chemotherapy in patients with a locally advanced ORL cancer: analysis of late toxicity].

Laszlo A, Rosset A, Hermann F, Ozsahin M, Zouhair A, Mirimanoff RO.

Cancer Radiother. 2001 Apr;5(2):130-7. French.

PMID:
11355577
7.

Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx.

Peters LJ, Harrison ML, Dimery IW, Fields R, Goepfert H, Oswald MJ.

Int J Radiat Oncol Biol Phys. 1988 Apr;14(4):623-33.

PMID:
2450858
8.

[Concomitant chemo-radiotherapy for locoregionally advanced nasopharygeal carcinoma].

Tian Y, Chua DT, Sham JS.

Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):429-31. Chinese.

PMID:
16188131
9.

[Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy].

Wu Y, Hu WH, Xia YF, Ma J, Liu MZ, Cui NJ.

Ai Zheng. 2005 Nov;24(11):1376-83. Chinese.

PMID:
16552967
10.

Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.

Ponzanelli A, Vigo V, Marcenaro M, Bacigalupo A, Gatteschi B, Ravetti JL, Corvò R, Benasso M.

Oral Oncol. 2008 Aug;44(8):767-74. Epub 2007 Dec 3.

PMID:
18061519
11.

Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.

Ho WK, Wei WI, Kwong DL, Sham JS, Tai PT, Yuen AP, Au DK.

Head Neck. 1999 Sep;21(6):547-53.

PMID:
10449671
12.

Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.

Lee AW, Ng WT, Hung WM, Choi CW, Tung R, Ling YH, Cheng PT, Yau TK, Chang AT, Leung SK, Lee MC, Bentzen SM.

Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1121-8. doi: 10.1016/j.ijrobp.2008.05.023. Epub 2008 Aug 23.

PMID:
18723296
13.

[Late course conformal radiotherapy combined with chemotherapy for stage III and IV a nasopharyngeal carcinoma].

Wu H, Lin Q, Yu ZH, Yang ZX, Feng LP.

Zhonghua Yi Xue Za Zhi. 2005 Jul 6;85(25):1778-80. Chinese.

PMID:
16253169
14.

[Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].

Liu MZ, He LR, Lu TX, Chen YY, Hu YH, Cui NJ, Xu GZ, Gao L, Xiao GL, Zhang SW, Cai Y, Li DM, Chen LH, Wang FY, Sun Q, Zhu L, Sheng G, Gao HJ, Bao YH.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):932-7. Chinese.

PMID:
17533747
15.
16.

Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.

Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ.

J Clin Oncol. 2008 Aug 1;26(22):3770-6. doi: 10.1200/JCO.2007.14.6647.

PMID:
18669465
17.

Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.

PMID:
19111400
18.

External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up.

Schinagl DA, Marres HA, Kappelle AC, Merkx MA, Pop LA, Verstappen SM, Kaanders JH.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):689-95. doi: 10.1016/j.ijrobp.2009.08.072. Epub 2010 Mar 16.

PMID:
20231060
19.

Radiation therapy for nasopharyngeal carcinoma. Retrospective review of 105 patients based on a survey of Kansai Cancer Therapist Group.

Chatani M, Teshima T, Inoue T, Azuma I, Yoshimura H, Oshitani T, Hashiba M, Nishiyama K, Tsutsui K, Fujimura T, et al.

Cancer. 1986 Jun 15;57(12):2267-71.

20.

The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y.

Cancer. 2006 Sep 15;107(6):1287-93.

Supplemental Content

Support Center